Related Experiment Video
Updated: Jul 3, 2026
12:32
High-resolution Respirometry to Measure Mitochondrial Function of Intact Beta Cells in the Presence of Natural Compounds
Published on: January 23, 2018
c-Jun N-terminal kinase pathways in diabetes.
Ruojing Yang1, James M Trevillyan
1Merck & Co. Inc., Metabolic Disorders, Rahway, NJ 07065, United States. ruojing_yang@merck.com
The International Journal of Biochemistry & Cell Biology
|August 6, 2008
Summary
Targeting c-Jun N-terminal kinases (JNK) can combat type 2 diabetes. Inhibiting JNK improves insulin sensitivity and metabolic control in mice, offering a promising therapeutic avenue.
Area of Science:
- Molecular Biology
- Endocrinology
- Metabolic Diseases
Background:
- Type 2 diabetes is a global epidemic driven by insulin resistance.
- c-Jun N-terminal kinases (JNK) are implicated in linking inflammation and insulin resistance.
- JNK signaling is crucial in metabolic regulation.
Purpose of the Study:
- To review the role of the JNK pathway in metabolic control.
- To explore the potential of JNK as a therapeutic target for type 2 diabetes.
Main Methods:
- Genetic disruption of c-Jun N-terminal kinase-1 (JNK1) gene in obese and diabetic mice.
- Inhibition of JNK using a small cell-permeable peptide in mice.
- Hepatic JNK inhibition via dominant-negative protein or RNA interference in mice.
Main Results:
- Genetic JNK1 disruption prevented insulin resistance development in mice.
- JNK inhibition improved insulin sensitivity and reduced blood glucose and insulin levels in mice.
- Hepatic JNK pathway influences lipid and lipoprotein homeostasis.
Conclusions:
- The c-Jun N-terminal kinase pathway is a key regulator of metabolic control.
- Targeting JNK offers a potential therapeutic strategy for type 2 diabetes treatment.
Related Concept Videos
01:26Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
01:24Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
01:20Pathophysiology of Diabetes
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
01:25cAMP-dependent Protein Kinase Pathways
Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
01:46Electron Transport Chain: Complex I and II
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
01:26Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...